当前位置: 首页 > 期刊 > 《医学信息》 > 2016年第18期
编号:12872887
不同分子亚型浸润性乳腺癌与淋巴结转移的临床(2)
http://www.100md.com 2016年5月7日 《医学信息》 2016年第18期
     参考文献:

    [1]PEROU C M,S?RLIE T, EISEN M B, et al. Molecular portraits of human breast tumours[J].Nature, 2000,406(6797): 747-752.

    [2] GOLDHIRSCH A, WINER E P, COATES A S, et al.Personalizing the treatment of women with early breast cancer:highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2013[J]. AnnOncol, 2013, 24(9): 2206-2223.

    [3]马燕飞,郭鹏威,卢冠铭,等.不同分子亚型老年性乳腺癌的临床病理特征与预后关系研究[J].河北医学,2015,7(21):1085-1088.

    [4]袁中玉,王树森,朱美琴,等.不同分子亚型乳腺癌的临床特征和预后[J].中华肿瘤杂志,2008,30(6):456-461.

    [5] Van Calster B,Vanden Bempt I,Drijkoningen M,et al.Axillarylymph node status of operable breast cancers by combined steroid receptor and HER-2 status:triple positive tumours are more likely lymph node positive[J].Breast Cancer Res Treat,2009,113(1):181-187.

    [6]惠锐.乳腺癌腋窝淋巴结转移规律的回顾性分析[J].肿瘤防治杂志,2004,1(9):933-936.

    [7]Carey L A,Dees E C,Sawyer L,et al.The triple negative paradox :primary tumor chemosensi-tivity of breast cancer subtypes[J].Clin Cancer Res, 2007, 13 :2329-2334., http://www.100md.com(朱晓菲 何娟 唐微)
上一页1 2